1 follower
Cybrexa Therapeutics is developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale. Our approach w... Read more
Per Hellsund
BigHat Bio
1 follower
Lisata Therapeutics
1 follower
Kyverna Therapeutics
7 followers
Madrigal Pharmaceuticals
2 followers
Vaxcyte
2 followers
AbbVie
204 followers
Surplus Solutions LLC
1 follower
Mirum Pharmaceuticals
3 followers
Incyte
17 followers
Novavax
10 followers
Slingshot Biosciences
1 follower
Explore companies